ORKA position history
The shares of Oruka Therapeutics (ORKA) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q3: 59,985 shares, $791K, 0.15% of portfolio, New
- 2025 Q4: 59,985 shares, $1.8M, 0.25% of portfolio
- 2026 Q1: 59,985 shares, $2.9M, 0.45% of portfolio
- 2026 Q2: 33,546 shares, $3.2M, 0.44% of portfolio, Reduce −44.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|